CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Harley C

    Harley Costley’s Immunotherapy Story

    Melanoma |  Diagnosed 2018 One day at a time, thankful for each day, and don’t give up Questions…
    May 27, 2019| CRI Staff
  • Erica Braden

    Erica Braden’s Immunotherapy Story

    Melanoma |  Diagnosed 2010 We are Blessed, But not Entitled Erica’s Story My story is quite long. We’ve…
    April 17, 2019| CRI Staff
  • Dave White

    David’s Immunotherapy Story

    Melanoma |  Diagnosed 2014 I am not a statistic. David’s Story Melanoma, that word had always been terrifying…
    December 1, 2018| CRI Staff
  • 30 Days of CRI Impact

    Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.

    June 1, 2018| Arthur N. Brodsky, PhD
  • Recent FDA Announcements Herald Advances in Personalized Approaches Against Cancer

    Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to…

    December 22, 2017| Arthur N. Brodsky, PhD
  • CICON17 Day 4 Recap: The Tumor Microenvironment and Oncolytic Viruses

    The final day of CICON17 explored two newer immunotherapy approaches that reflect broader understanding of tumor-immune interactions…

    September 10, 2017| Arthur N. Brodsky, PhD
  • AACR17 Update: Checkpoint Immunotherapy Clinical Trials in Melanoma and Lung Cancer

    In-depth analysis of long-term clinical trial data provides important insights for doctors treating…

    April 6, 2017| Arthur N. Brodsky, PhD
  • Therese B

    Thèrése B’s Immunotherapy Story

    Melanoma I’m amazed I’m still alive because I know how terrible a disease it is. Thèrése’s Story…
    March 16, 2017| CRI Staff
  • Mary Elizabeth Williams

    Mary Elizabeth Williams’s Immunotherapy Story

    Melanoma |  Diagnosed 2010 There’s no question in my mind that immunotherapy saved my life. Mary Elizabeth’s Story…
    March 16, 2017| CRI Staff
Previous Page
1 2 3 4 5
Next Page

Cancer Research Institute
29 Broadway, Floor 4

New York, NY  10006-3111

Facebook Icon
X icon
YouTube icon
LinkedIn icon
Instagram icon
Threads icon
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Type
    • Cancer Type
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Research Programs
    • Clinical Programs
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Donate
    • Ways to give
    • Fundraise
    • Events
    • Partnership
    • Contact

Uniting for a World Immune to Cancer

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
  • Site Map

*Immunotherapy results may vary from patient to patient.

©2025, Cancer Research Institute